First GREG HTA Expert Forum Meeting
The first successful Health Technology Assessment (HTA) Expert Forum meeting was held virtually on 23 February 2026.
The meeting included 14 HTA experts that assess Real-World Evidence (RWE) submissions, generate national RWE to inform local pricing and reimbursement decisions, or work at a policy level to support RWE developments in HTA. These experts from across Europe and Canada contributed expertise relating to the use of RWE to support HTA of medicines, devices...
Welcome to the 1st GREG Newsletter
Issue 1 - February 2026
As coordinators of the GREG project, we are thrilled to share the first edition of the GREG Newsletter with you. These newsletters will be published bi-annually and provide regular updates including progress of the project, achievements and upcoming events. In addition, each issue will spotlight a key topic. We hope you enjoy reading this newsletter...
GREG at ESC Congress 2025
Real-world evidence and the GREG initiative – bridging regulation and data innovation in cardiology
The GREG Consortium has taken part in the European Society of Cardiology (ESC) annual Congress, held in Madrid from August 29 to September 1, 2025. This event continues to be a cornerstone in the global cardiology calendar, bringing together thought leaders, clinicians, researchers, and regulators and policymakers from around the world to share knowledge, foster...
GREG Kick-Off Meeting in Rotterdam
The Start of a Journey
The GREG project officially commenced with a two-day Kick-Off Meeting held in Rotterdam on 14–15 May, where around 80 participants from academia, industry, regulatory bodies, and patient organisations took part. Supported by the Innovative Health Initiative (IHI JU), GREG aims to co-create and deliver evidence-based guidance and tools to support the generation and use of...
Launch of the GREG Project
Generate, pilot-test, and disseminate evidence-based guidance and tools for the use of RWE
The GREG project has been officially launched to address persistent challenges in the generation, implementation, and acceptance of Real-World Evidence (RWE) for medicines, medical devices, and drug-device combinations in Europe. The GREG Initiative Will Tackle Persistent Challenges in Real-World Evidence While the interest and ability to use Real-World Data (RWD) sources to generate RWE have...
Newsalbert2026-02-19T11:35:32+02:00
